Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 2/2009

01-04-2009 | Research Article

Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran

Authors: Ghazal Vessal, Zeinab Mardani, Mehri Mollai

Published in: International Journal of Clinical Pharmacy | Issue 2/2009

Login to get access

Abstract

Objective Adverse Drug Reactions (ADRs) are a major cause of patient morbidity and mortality. Spontaneous reporting of ADRs remains the cornerstone of pharmacovigilance and is important in maintaining patient safety. In order to determine whether our pharmacovigilance system could be improved, and identify reasons for under-reporting, a study to investigate the role of pharmacists in ADR reporting was performed in Shiraz. Setting: The pharmacies in Shiraz, capital of Fars province in Iran. Methods A questionnaire was prepared to investigate knowledge and attitude of pharmacists regarding ADR reporting. The questionnaire was given to 200 pharmacists who participated in a pharmacist association meeting. Main outcomes measured: The knowledge of pharmacovigilance practice, reasons for not reporting ADR, and perceptions of the Iranian pharmacists on pharmacovigilance practice were evaluated Results The response rate was 55% (n = 110). 29% of the respondents were not aware of the Iranian Pharmacovigilance Center. More than half of those responding felt that ADR reporting should be voluntary, while 26% felt it was a professional obligation. As for the purposes of ADR reporting scheme, 60% of the pharmacists falsely believed that monitoring ADR spontaneous reports aims at measuring the incidence of ADR. 42% of the pharmacists indicated that they have suspected an ADR without reporting it. Doubt about causality was the major reason for not reporting an ADR. Although our ADR center states that all suspected reactions to any drug on the market must be reported, only 17% of the respondents seemed to be aware of this responsibility. Conclusion Our pharmacists have little knowledge regarding the operation, purposes, and usefulness of ADR spontaneous reporting system. However, education and training will be important in maintaining and increasing ADR reports from pharmacists.
Literature
1.
go back to reference Pirmohamed M, Breckenridge A, Kitteringham N, Park BK. Adverse drug reactions. BMJ. 1998;316:1295–8.PubMed Pirmohamed M, Breckenridge A, Kitteringham N, Park BK. Adverse drug reactions. BMJ. 1998;316:1295–8.PubMed
3.
go back to reference Muehlberger N, Schneeweiss S, Hasford J. Adverse drug reaction monitoring-Cost and benefit considerations part I: frequency of adverse drug reactions causing hospital admissions. Pharmacoepidemiol Drug Saf. 1997;6(3):S71–7. doi:10.1002/(SICI)1099-1557(199710)6:3+<S71::AID-PDS282>3.3.CO;2-9.PubMedCrossRef Muehlberger N, Schneeweiss S, Hasford J. Adverse drug reaction monitoring-Cost and benefit considerations part I: frequency of adverse drug reactions causing hospital admissions. Pharmacoepidemiol Drug Saf. 1997;6(3):S71–7. doi:10.1002/(SICI)1099-1557(199710)6:3+<S71::AID-PDS282>3.3.CO;2-9.PubMedCrossRef
6.
go back to reference Wiholm BE, Olsson S, Moore N, Wood S. Spontaneous reporting systems outside the United States. In: Strom BL, editor. Pharmacoepidemiology. Chichester: John Wiley & Sons Ltd; 1994. p. 139–55. Wiholm BE, Olsson S, Moore N, Wood S. Spontaneous reporting systems outside the United States. In: Strom BL, editor. Pharmacoepidemiology. Chichester: John Wiley & Sons Ltd; 1994. p. 139–55.
7.
go back to reference Ramezani Tehrani B, Javid Nikoo N. Report of the Iranian Pharmacovigilance Center. Razi J. 2007;12:85–90. Article in Persian. Ramezani Tehrani B, Javid Nikoo N. Report of the Iranian Pharmacovigilance Center. Razi J. 2007;12:85–90. Article in Persian.
10.
go back to reference Bateman DN, Sanders GLS, Rawling MD. Attitudes to adverse drug reaction reporting in the northern region. Br J Clin Pharmacol. 1992;34:421–6.PubMed Bateman DN, Sanders GLS, Rawling MD. Attitudes to adverse drug reaction reporting in the northern region. Br J Clin Pharmacol. 1992;34:421–6.PubMed
11.
go back to reference Belton K. The European Pharmacovigilance Research Group. attitude survey of adverse drug reaction reporting by healthcare professionals across the European Union. Eur J Clin Pharmacol. 1997;52:423–7. doi:10.1007/s002280050314.PubMedCrossRef Belton K. The European Pharmacovigilance Research Group. attitude survey of adverse drug reaction reporting by healthcare professionals across the European Union. Eur J Clin Pharmacol. 1997;52:423–7. doi:10.​1007/​s002280050314.PubMedCrossRef
13.
go back to reference Lee KK, Chan TY, Raymond K, Critchley JA. Pharmacists’ attitudes toward adverse drug reactions reporting in Hong Kong. Ann Pharmacother. 1994;28(12):1400–3.PubMed Lee KK, Chan TY, Raymond K, Critchley JA. Pharmacists’ attitudes toward adverse drug reactions reporting in Hong Kong. Ann Pharmacother. 1994;28(12):1400–3.PubMed
15.
go back to reference Generali JA, Danish MA, Rosenbaum SE. Knowledge of and attitudes about adverse drug reaction reporting among Rhode Island pharmacists. Ann Pharmacother. 1995;29(4):365–9.PubMed Generali JA, Danish MA, Rosenbaum SE. Knowledge of and attitudes about adverse drug reaction reporting among Rhode Island pharmacists. Ann Pharmacother. 1995;29(4):365–9.PubMed
17.
go back to reference Zerrin Toklu H, Uysal MK. The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul. Pharm World Sci. 2008;30(5):556–62. doi:10.1007/s11096-008-9209-4.CrossRef Zerrin Toklu H, Uysal MK. The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul. Pharm World Sci. 2008;30(5):556–62. doi:10.​1007/​s11096-008-9209-4.CrossRef
18.
go back to reference Granas AG, Buajordet M, Stenberg-Nilsen H, et al. Pharmacists’ attitudes toward the reporting of suspected adverse drug reactions in Norway. Pharmacoepidemiol Drug Saf. 2007;16:429–34. doi:10.1002/pds.1298.PubMedCrossRef Granas AG, Buajordet M, Stenberg-Nilsen H, et al. Pharmacists’ attitudes toward the reporting of suspected adverse drug reactions in Norway. Pharmacoepidemiol Drug Saf. 2007;16:429–34. doi:10.​1002/​pds.​1298.PubMedCrossRef
20.
go back to reference Walker SR, Lumley CE. The attitudes of general practitioners to the monitoring and reporting of adverse drug reactions. Pharm Med. 1986;1:195–203. Walker SR, Lumley CE. The attitudes of general practitioners to the monitoring and reporting of adverse drug reactions. Pharm Med. 1986;1:195–203.
21.
go back to reference Lumley CE, Walker SR, Hall GC, Staunton N, Grob PR. The under-reporting of adverse drug reactions seen in general practice. Pharm Med. 1986;1:205–12. Lumley CE, Walker SR, Hall GC, Staunton N, Grob PR. The under-reporting of adverse drug reactions seen in general practice. Pharm Med. 1986;1:205–12.
22.
go back to reference Belton KJ, Lewis SC, Payne S, Rawlins MD, Wood S. Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom. Br J Clin Pharmacol. 1995;39(3):223–6.PubMed Belton KJ, Lewis SC, Payne S, Rawlins MD, Wood S. Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom. Br J Clin Pharmacol. 1995;39(3):223–6.PubMed
Metadata
Title
Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran
Authors
Ghazal Vessal
Zeinab Mardani
Mehri Mollai
Publication date
01-04-2009
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 2/2009
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-008-9276-6

Other articles of this Issue 2/2009

International Journal of Clinical Pharmacy 2/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.